This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1965 Aug;156(2):467-88.

Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action

P M Lish, J A Labudde, E L Peters, S I Robbins

PMID: 4380481

Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action

P M Lish et al. Arch Int Pharmacodyn Ther. 1965 Aug.

. 1965 Aug;156(2):467-88.

Authors

P M Lish, J A Labudde, E L Peters, S I Robbins

PMID: 4380481

No abstract available

PubMed Disclaimer

Similar articles

Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
Southgate PJ. Southgate PJ. Arch Int Pharmacodyn Ther. 1972 Apr;196(2):376-82. Arch Int Pharmacodyn Ther. 1972. PMID: 4401084 No abstract available.
Anticholinergic evaluation of 1,1-diphenyl-2-(1-methyl-3-pyrrolidyl) ethanol and N-(2'5'-dimethyl-1'-piperidylmethyl) benzilamide.
Carrano RA, Malone MH. Carrano RA, et al. Arch Int Pharmacodyn Ther. 1966 Sep;163(1):96-102. Arch Int Pharmacodyn Ther. 1966. PMID: 4381959 No abstract available.
A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor.
Fredericks CM, Anderson GF, Kreulen DL. Fredericks CM, et al. Invest Urol. 1975 Jan;12(4):317-9. Invest Urol. 1975. PMID: 235500
Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
Scarpignato C, Bianchi Porro G. Scarpignato C, et al. Int J Clin Pharmacol Res. 1985;5(6):467-77. Int J Clin Pharmacol Res. 1985. PMID: 3912339 Review.
Central versus peripheral effects of muscarinic antagonists: the limitations of quaternary ammonium derivatives.
Moore H, Dudchenko P, Comer KS, Bruno JP, Sarter M. Moore H, et al. Psychopharmacology (Berl). 1992;108(1-2):241-3. doi: 10.1007/BF02245315. Psychopharmacology (Berl). 1992. PMID: 1410143 Review. No abstract available.

See all similar articles

Cited by

Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.
Jones SE, Shuba LM, Zhabyeyev P, McCullough JR, McDonald TF. Jones SE, et al. Br J Pharmacol. 2000 Sep;131(2):245-54. doi: 10.1038/sj.bjp.0703595. Br J Pharmacol. 2000. PMID: 10991917 Free PMC article.
The use of oxybutynin in urological practice.
Kirkali Z, Whitaker RH. Kirkali Z, et al. Int Urol Nephrol. 1987;19(4):385-91. doi: 10.1007/BF02550355. Int Urol Nephrol. 1987. PMID: 3429165
Current concepts in the treatment of disorders of micturition.
Andersson KE. Andersson KE. Drugs. 1988 Apr;35(4):477-94. doi: 10.2165/00003495-198835040-00006. Drugs. 1988. PMID: 3292211 Review.
The pharmacokinetics of oxybutynin in man.
Douchamps J, Derenne F, Stockis A, Gangji D, Juvent M, Herchuelz A. Douchamps J, et al. Eur J Clin Pharmacol. 1988;35(5):515-20. doi: 10.1007/BF00558247. Eur J Clin Pharmacol. 1988. PMID: 3234461
Management of overactive bladder with transdermal oxybutynin.
Starkman JS, Dmochowski RR. Starkman JS, et al. Rev Urol. 2006 Summer;8(3):93-103. Rev Urol. 2006. PMID: 17043706 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database